Misoprostol (Cytotec)

ISSN 0256-5004 (Print)

AIMS Journal Vol 13 No 3

IMPORTANT DRUG WARNING CONCERNING UNAPPROVED USE OF INTRAVAGINAL OR ORAL MISOPROSTOL IN PREGNANT WOMEN FOR INDUCTION OR LABOR OR ABORTION

August 23, 2000
Re: Cytotec (misoprostol)

Dear Health Care Practitioner:

The purpose of this letter is to remind you that Cytotec administration by any route is contraindicated in women who are pregnant because it can cause abortion. Cytotec is not approved for the induction of labor or abortion.

Cytotec is indicated for the prevention of NSAID (nonsteroidal anti- inflammatory drugs, including aspirin) - induced gastric ulcers in patients at high risk of complications from gastric ulcer, eg the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.

The uterotonic effect of cytotec is an inherent property of prostaglandin E1 (PGE1), of which Cytotec is a stable, orally active, synthetic analog. Searle has become aware of some instances where Cytotec, outside of its approved indication, was used as a cervical ripening agent prior to termination of pregnancy, or for induction of labor, in spite of the specific contraindications to its use during pregnancy.

Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy or salpingo-oophorectomy, amniotic fluid embolism, severe vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain.

Searle has not conducted research concerning the use of Cytotec for cervical ripening prior to termination of pregnancy or for induction of labor, nor does Searle intend to study or support these uses. Therefore, Searle is unable to provide risk information for Cytotec when it is used for such purposes. In addition to the known and unknown acute risks to the mother and fetus, the effect of Cytotecon the later growth, development and functional maturation of the child when Cytotec is used for induction of labor or cervical ripening has not been established.

Searle promotes the use of Cytotec only for its approved indication. Please read the enclosed updated complete Prescribing Information for Cytotec.

Further information may be obtained by calling 1-800-323-4204.

Michael Cullen MD
Medical Director, US
Searle


AIMS supports all maternity service users to navigate the system as it exists, and campaigns for a system which truly meets the needs of all. AIMS does not give medical advice, but instead we focus on helping women to find the information that they need to make informed decisions about what is right for them, and support them to have their decisions respected by their health care providers. The AIMS Helpline volunteers will be happy to provide further information and support. Please email helpline@aims.org.uk or ring 0300 365 0663.

Latest Content

Journal

« »

On message - What can we learn from…

AIMS Journal, 2020, Vol 33, No 1 By Sophie Martin We all have continuous internal monologues running day and night 1 . Much of what the voices in our heads say is a refle…

Read more

Getting to grips with the first Ock…

AIMS Journal, 2020, Vol 33, No 1 By the AIMS Campaigns Team Donna Ockenden and her team’s first – interim – report was published in December 2020. It starts to lay bare h…

Read more

Editorial: Salutogenesis - Putting…

AIMS Journal, 2020, Vol 33, No 1 By Alex Smith The theme for our March edition of the AIMS Journal is Salutogenesis. Salutogenesis is a term introduced by sociologist and…

Read more

Events

« »

AIMS 60th Anniversary Event - Confe…

POSTPONED FROM JUNE 2020 Making a difference past and future The purpose of the day is to celebrate what Birth Activists in general and AIMS in particular have achieved,…

Read more

AIMS Annual General Meeting 2020

This year’s AGM will be an online meeting, so we plan to keep it to two hours. However, there will be the opportunity to stay, chat and socialise with friends and colleag…

Read more

Latest Campaigns

« »

Report on the But Not Maternity/Nat…

AIMS and our partners in the But Not Maternity Alliance and National Maternity Voices organised a webinar for MVP/MSLC representatives. The purpose was to raise awareness…

Read more

Press release: We have a roadmap fo…

AIMS and our partners in the But Not Maternity Alliance have issued a press release on the nationwide status of maternity restrictions highlighting the huge variation bet…

Read more

AIMS Submission to the Violence Aga…

AIMS has responded to the call for evidence to inform the Government’s Violence Against Women and Girls (VAWG) strategy 2021 to 2024 Violence Against Women and Girls (VAW…

Read more